Drugs / REVO-UWD-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06653010 | Oct 2024 → Oct 2027 | colorectal cancer | Wondercel Biotech (ShenZhen) | Suspended | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | REVO-UWD-01 | “Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer” NCT06653010 ↗ |
| Known as | Allogeneic CAR-T cells (REVO-UWD-01) | “Allogeneic CAR-T cells (REVO-UWD-01)” NCT06653010 ↗ |
| Modality | Cell therapy | “novel universal CAR-T technology” NCT06653010 ↗ |